Биорегуляционная системная медицина: от теории к практике

1. Goldman A.W. et al. Bioregulatory systems medicine:aninnovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient’s autoregulatory capacity? Front Physiol. 2015;(6):225. doi: 10.3389/ fphys.2015.00225.

2. Reckeweg H.H. Synergism as a Pathogenetic, Homotoxicological and Pharmacological Principle Biologische Medizin. 1974;(1):1-22.

3. Смит А. Теоретические основы биорегуляционной медицины. Фармация. 2016;(8):5356. Режим доступа: https://pharmaciyajournal.ru/en/node/37934. Smit A. Bioregulatory medicine: Theoretical aspects. Farmatsiya = Pharmacy. 2016;(8):5356. (In Russ.) Available at: https://pharmaciyajournal.ru/en/node/37934.

4. St. Laurent G. III, Seilheimer B., Tackett M., Zhou J., Shtokalo D., Vyatkin Y., Ri M., et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci. 2017;(4):57. doi: 10.3389/fmolb.2017.00057 .

5. Herzberger G., Weiser M. Homeopathic Treatment of Infections of Various Origins: A Prospective Study. Biomed Ther 1997;XV(4):123-127.

6. Roeska K., Seilheimer B. Antiviral activity of Engystol(R) and Gripp-Heel(R): an in-vitro assessment. J Immune Based Ther Vaccines. 2010;(8):6. doi: 10.1186/1476-8518-8-6.

7. Enbergs H. Effects of the homeopathic preparation Engystol® on interferon-γ production by human T-lymphocytes. Immunol Invest. 2006;35(1):19-27. doi: 10.1080/08820130500496753.